{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:36:00Z","timestamp":1761896160462},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T00:00:00Z","timestamp":1444176000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12902-015-0051-0","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T10:20:09Z","timestamp":1444213209000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Treatment intensification using long-acting insulin \u2013predictors of future basal insulin supported oral therapy in the DIVE registry"],"prefix":"10.1186","volume":"15","author":[{"name":"for the DIVE study group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Danne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Bluhmki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Seufert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Kaltheuner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Rathmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Beyersmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bramlage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,7]]},"reference":[{"issue":"21","key":"51_CR1","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","volume":"281","author":"RC Turner","year":"1999","unstructured":"Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999;281(21):2005\u201312.","journal-title":"JAMA"},{"issue":"1","key":"51_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193\u2013203.","journal-title":"Diabetes Care"},{"key":"51_CR3","first-page":"S5","volume":"37 Suppl 1","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association. Executive summary: standards of medical care in diabetes--2014. Diabetes Care. 2014;37 Suppl 1:S5\u201313.","journal-title":"Diabetes Care"},{"issue":"6","key":"51_CR4","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.2337\/dc13-2743","volume":"37","author":"P Home","year":"2014","unstructured":"Home P, Riddle M, Cefalu WT, Bailey CJ, Bretzel RG, Del Prato S, et al. Insulin therapy in people with type 2 diabetes: opportunities and challenges? Diabetes Care. 2014;37(6):1499\u2013508.","journal-title":"Diabetes Care"},{"issue":"9","key":"51_CR5","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1055\/s-0029-1239559","volume":"117","author":"S Matthaei","year":"2009","unstructured":"Matthaei S, Bierwirth R, Fritsche A, Gallwitz B, Haring HU, Joost HG, et al. Medical antihyperglycaemic treatment of type 2 diabetes mellitus: update of the evidence-based guideline of the German Diabetes Association. Exp Clin Endocrinol Diabetes. 2009;117(9):522\u201357.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"11","key":"51_CR6","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.2337\/diacare.26.11.3080","volume":"26","author":"MC Riddle","year":"2003","unstructured":"Riddle MC, Rosenstock J, Gerich J. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003;26(11):3080\u20136.","journal-title":"Diabetes Care"},{"issue":"6","key":"51_CR7","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.2337\/dc05-1365","volume":"29","author":"K Hermansen","year":"2006","unstructured":"Hermansen K, Davies M, Derezinski T, Martinez Ravn G, Clauson P, Home P. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetes Care. 2006;29(6):1269\u201374.","journal-title":"Diabetes Care"},{"key":"51_CR8","volume":"4","author":"AN Goudswaard","year":"2004","unstructured":"Goudswaard AN, Furlong NJ, Rutten GE, Stolk RP, Valk GD. Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2004;4, CD003418.","journal-title":"Cochrane Database Syst Rev"},{"issue":"17","key":"51_CR9","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1056\/NEJMoa075392","volume":"357","author":"RR Holman","year":"2007","unstructured":"Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, et al. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med. 2007;357(17):1716\u201330.","journal-title":"N Engl J Med"},{"issue":"10 Suppl","key":"51_CR10","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.amjmed.2014.07.003","volume":"127","author":"S Edelman","year":"2014","unstructured":"Edelman S, Pettus J. Challenges associated with insulin therapy in type 2 diabetes mellitus. Am J Med. 2014;127(10 Suppl):S11\u20136.","journal-title":"Am J Med"},{"issue":"3","key":"51_CR11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1177\/0145721708317869","volume":"34","author":"ME Larkin","year":"2008","unstructured":"Larkin ME, Capasso VA, Chen CL, Mahoney EK, Hazard B, Cagliero E, et al. Measuring psychological insulin resistance: barriers to insulin use. Diabetes Educ. 2008;34(3):511\u20137.","journal-title":"Diabetes Educ"},{"issue":"11","key":"51_CR12","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.2337\/diacare.28.11.2673","volume":"28","author":"M Peyrot","year":"2005","unstructured":"Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005;28(11):2673\u20139.","journal-title":"Diabetes Care"},{"issue":"4","key":"51_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.pcd.2012.06.001","volume":"6","author":"K Kostev","year":"2012","unstructured":"Kostev K, Dippel FW. Predictors for the initiation of a basal supported oral therapy (BOT) in type 2 diabetic patients under real-life conditions in Germany. Prim Care Diabetes. 2012;6(4):329\u201335.","journal-title":"Prim Care Diabetes"},{"issue":"18","key":"51_CR14","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1055\/s-0033-1343144","volume":"138","author":"T Danne","year":"2013","unstructured":"Danne T, Kaltheuner M, Koch A, Ernst S, Rathmann W, Russmann HJ, et al. [\u201cDIabetes Versorgungs-Evaluation\u201d (DIVE)--a national quality assurance initiative at physicians providing care for patients with diabetes]. Dtsch Med Wochenschr. 2013;138(18):934\u20139.","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"51_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1373\/clinchem.2003.024802","volume":"50","author":"W Hoelzel","year":"2004","unstructured":"Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem. 2004;50(1):166\u201374.","journal-title":"Clin Chem"},{"issue":"3","key":"51_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/0962280206074463","volume":"16","author":"S Buuren van","year":"2007","unstructured":"van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16(3):219\u201342.","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"51_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i02","volume":"45","author":"Y-S Su","year":"2011","unstructured":"Su Y-S, Gelman A, Hill J, Yajima M. Multiple imputation with diagnostics (mi) in R: opening windows into the black Box. Journal of Statistical Software. 2011;45(2):1\u201331.","journal-title":"Journal of Statistical Software"},{"key":"51_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for noneresponse in surveys","author":"DB Rubin","year":"1987","unstructured":"Rubin DB. Multiple imputation for noneresponse in surveys. New York: J. Wiley & Sons; 1987."},{"issue":"1","key":"51_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/1076029612449899","volume":"19","author":"M Spannagl","year":"2013","unstructured":"Spannagl M, Melzer N, Bramlage P, Englert C, Eisele R. Prospective, non-interventional study on the real-world use of certoparin in daily practice--the PROMEMBER study. Clin Appl Thromb Hemost. 2013;19(1):86\u201391.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"51_CR20","first-page":"243","volume":"60","author":"JA Spoelstra","year":"2002","unstructured":"Spoelstra JA, Stol RP, de Bruyne MC, Erkens JA, Herings RM, Leufkens HG, et al. Factors associated with switching from oral hypoglycaemic agents to insulin therapy. Neth J Med. 2002;60(6):243\u20138.","journal-title":"Neth J Med"},{"issue":"7656","key":"51_CR21","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1136\/bmj.39560.442095.AD","volume":"336","author":"P Home","year":"2008","unstructured":"Home P, Mant J, Diaz J, Turner C. Management of type 2 diabetes: summary of updated NICE guidance. BMJ. 2008;336(7656):1306\u20138.","journal-title":"BMJ"},{"issue":"1","key":"51_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.diabet.2012.08.002","volume":"39","author":"J Vora","year":"2013","unstructured":"Vora J, Bain SC, Damci T, Dzida G, Hollander P, Meneghini LF, et al. Incretin-based therapy in combination with basal insulin: a promising tactic for the treatment of type 2 diabetes. Diabetes Metab. 2013;39(1):6\u201315.","journal-title":"Diabetes Metab"},{"issue":"1","key":"51_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.diabres.2007.07.001","volume":"79","author":"M Civera","year":"2008","unstructured":"Civera M, Merchante A, Salvador M, Sanz J, Martinez I. Safety and efficacy of repaglinide in combination with metformin and bedtime NPH insulin as an insulin treatment regimen in type 2 diabetes. Diabetes Res Clin Pract. 2008;79(1):42\u20137.","journal-title":"Diabetes Res Clin Pract"},{"key":"51_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2288-11-86","volume":"11","author":"A Allignol","year":"2011","unstructured":"Allignol A, Schumacher M, Wanner C, Drechsler C, Beyersmann J. Understanding competing risks: a simulation point of view. BMC Med Res Methodol. 2011;11:86.","journal-title":"BMC Med Res Methodol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-015-0051-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12902-015-0051-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-015-0051-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T15:03:59Z","timestamp":1475334239000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-015-0051-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["51"],"URL":"https:\/\/doi.org\/10.1186\/s12902-015-0051-0","relation":{},"ISSN":["1472-6823"],"issn-type":[{"type":"electronic","value":"1472-6823"}],"subject":[],"published":{"date-parts":[[2015,10,7]]},"article-number":"54"}}